Phthoxazolin A inhibits prostate cancer growth by modulating tumor-stromal cell interactions

Cancer Science

Volumn 100, Issue 1, 2009, Pages 150-157

  Kawada, Manabu ^a   Inoue, Hiroyuki ^a   Usami, Ihomi ^a   Ikeda, Daishiro ^a  

^a Numazu Bio Medical Research Institute   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANTINEOPLASTIC AGENT; BETA ACTIN; INTHOMYCIN B; NATURAL PRODUCT; PHTHOXAZOLIN A; PROTEIN KINASE B; SMAD2 PROTEIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VIMENTIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL COUNT; CELL INTERACTION; COCULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MALE; MYOFIBROBLAST; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CELL COMMUNICATION; CELL LINE, TUMOR; FATTY ALCOHOLS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; OXAZOLES; POLYUNSATURATED ALKAMIDES; PROSTATIC NEOPLASMS; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 58149307940     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.00996.x     Document Type: Article

References (38)

1. Stahtea XN, Roussidis AE, Kanakis I et al. Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activation. Int J Cancer 2007; 121: 2808-14.
2. Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science 2002; 296: 1046-9.
3. Karnoub AE, Dash AB, Vo AP et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557-63.
4. Hwang RF, Moore T, Arumugam T et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 2008; 68: 918-26.
5. Grossfeld GD, Hayward SW, Tlsty TD, Cunha GR. The role of stroma in prostatic carcinogenesis. Endocr Relat Cancer 1998; 5: 253-70.
6. Dvorak HF. Tumors: Wounds that do not heal. N Eng J Med 1986; 315: 1650-9.
7. Tuxhorn JA, Ayala GE, Smith MJ, Smith VC, Dang TD, Rowley DR. Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and extracellular matrix remodeling. Clin Cancer Res 2002; 8: 2912-23.
8. Delinassios JG. Cytocidal effect of human fibroblasts on HeLa cells in.vitro. Biol Cell 1987; 59: 69-77.
9. Picard O, Rolland Y, Poupon MF. Fibroblast-dependent tumorigenicity of cells in nude mice: Implication for implantation of metastases. Cancer Res 1986; 46: 3290-4.
10. Camps JL, Chang SM, Hsu TC et al. Fibroblast-mediated acceleration of human epithelial tumor growth in.vivo. Proc Natl Acad Sci USA 1990; 87: 75-9.
11. Micke P, Ostman A. Tumor-stroma interaction: Cancer-associated fibroblasts as novel targets in anti-cancer therapy? Lung Cacner 2004; 45: S163-75.
12. Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer progression. J Urol 2001; 166: 2472-83.
13. Wernert N. The multiple roles of tumor stroma. Virchows Arch 1997; 430: 433-43.
14. Pollak M, Beamer W, Zhang JC. Insulin-like growth factors and prostate cancer. Cancer Metastasis Rev 1999; 17: 383-90.
15. Kawada M, Inoue H, Masuda T, Ikeda D. Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer. Cancer Res 2006; 66: 4419-25.
16. Peehl DM, Sellers RG. Induction of smooth muscle cell phenotype in cultured human prostatic stromal cells. Exp Cell Res 1997; 232: 208-15.
17. Rønnov-Jessen L, Petersen OW. Induction of α-smooth muscle actin by transforming growth factor-β 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest 1993; 68: 696-707.
18. Tuxhorn JA, McAlhany SJ, Yang F, Dang TD, Rowley DR. Inhibition of transforming growth factor-β activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Cancer Res 2002; 62: 6021-5.
19. Steiner MS, Barrack ER. Transforming growth factor-β 1 overproduction in prostate cancer: Effects on growth in.vivo and in.vitro. Mol Endocrinol 1992; 6: 15-25.
20. Cui W, Fowlis DJ, Bryson S et al. TGF-β1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996; 86: 531-42.
21. Bhowmick NA, Chytil A, Plieth D et al. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004; 303: 848-51.
22. Kawada M, Inoue H, Arakawa M, Ikeda D. Transforming growth factor-β1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I. Anticancer Res 2008; 28: 721-30.
23. Date K, Matsumoto K, Shimura H, Tanaka M, Nakamura T. HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor. FEBS Lett 1997; 420: 1-6.
24. Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T. Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene 1998; 17: 3045-54.
25. Kawada M, Ishizuka M, Takeuchi T. Enhancement of antiproliferative effects of interleukin-1β and tumor necrosis factor-α on human prostate cancer LNCaP cells by coculture with normal fibroblasts through secreted interleukin-6. Jpn J Cancer Res 1999; 90: 546-54.
26. Kawada M, Inoue H, Usami I et al. Establishment of a highly tumorigenic LNCaP cell line having inflammatory cytokine resistance. Cancer Lett 2006; 242: 46-52.
27. Kawada M, Yoshimoto Y, Minamiguchi K et al. A microplate assay for selective measurement of growth of epithelial tumor cells in direct coculture with stromal cells. Anticancer Res 2004; 24: 1561-8.
28. Fukazawa H, Mizuno S, Uehara Y. A microplate assay for quantitation of anchorage-independent growth of transformed cells. Anal Biochem 1995; 228: 83-90.
29. Kawada M, Masuda T, Ishizuka M, Takeuchi T. 15-Deoxyspergualin inhibits Akt kinase activation and phosphatidylcholine synthesis. J Biol Chem 2002; 277: 27.765-71.
30. Omura S, Tanaka Y, Kanaya I, Shinose M, Takahasi Y. Phthoxazolin, a specific inhibitor of cellulose biosynthesis, produced by a strain of streptomyces sp. J Antibiot 1990; 43: 1034-6.
31. Tanaka Y, Kanay I, Takahashi Y, Shinose M, Tanaka H, Omura S. Phthoxazolin A, a specific inhibitor of cellulose biosynthesis from microbial origin. I. Discovery, taxonomy of producing microorganism, fermentation, and biological activity. J Antibiot 1993; 46: 1208-13.
32. Tanaka Y, Kanaya I, Shiomi K, Tanaka H, Omura S. Phthoxazolin A, a specific inhibitor of cellulose biosynthesis from microbial origin. II. Isolation, physico-chemical properties, and structural elucidation. J Antibiot 1993; 46: 1214-18.
33. Matsuyama S, Iwadate M, Kondo M et al. SB-431542 and Gleevec inhibit transforming growth factor-β-induced proliferation of human osteosarcoma cells. Cancer Res 2003; 63: 7791-8.
34. Hjelmeland MD, Hjelmeland AB, Sathornsumetee S et al. SB-431542, a small molecule transforming growth factor-β-receptor antagonist, inhibits human glioma cell line proliferation and motility. Mol Cancer Ther 2004; 3: 737-45.
35. Verona EV, Elkahloun AG, Yang J, Bandyopadhyay A, Yeh I, Sun L. Transforming growth factor-β signaling in prostate stromal cells supports prostate carcinoma growth by up-regulating stromal genes related to tissue remodeling. Cancer Res 2007;67: 5737-46.
36. Li W, Wu C, Bebbo PG, Olumi AF. Stromally expressed c-jun regulates proliferation of prostate epithelial cells. Am J Pathol 2007; 171: 1189-98.
37. Raina K, Blouin M, Singh RP et al. Dietary feeding of silibinin inhibits prostate tumor growth and progression in transgenic adenocarcinoma of the mouse prostate model. Cancer Res 2007; 67: 11.083-91.
38. Gregory C, Kim D, Ye P et al. Androgen receptor up-regulates insulin-like growth factor binding protein-5 (IGFBP-5) expression in a human prostate cancer xenograft. Endocrinology 1999; 140: 2372-81.